MTIF2 and neoplasm: In addition, the drug resistance of tumor cells is weakened, the overexpression of MTIF2 and ICD-related DAMPs is significantly reduced, DC maturation/activation is impaired, tumor immunosuppression occurs, and tumor cells rapidly proliferate and patients have a poor prognosis (65).